Over 10 million people around the world are suffering with stiffness and slowness caused by Parkinson’s Disease. CUE1, a focused vibrotactile stimulation device, has granted all of the pilot participants improved movement. Participants claimed that they felt their movement was smoother and better coordinated when using the device.
| Website | http://charconeurotech.com |
| Employees | 72 (12 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript
,
HTML
,
PHP
+30 more
(view full list)
|
| Industry | Medical Equipment Manufacturing |
| Keywords | Parkinson's Disease Treatment, Movement Disorder Treatment, Movement Improvement, Neuromodulation, Mobility Enhancement, Neurological Rehabilitation, Functional Improvement, Motor Skills, Quality Of Life |
| Competitors | Medtronic, Pfizer, Boston Scientific, St. Jude Medical, Neuralink, NeuroPace, Blackrock Neurotech, Soterix Medical, Synapse Biomedical, CereGate +21 more (view full list) |
Looking for a particular Charco employee's phone or email?
Andrew Mullen is the CEO of Charco.
12 people are employed at Charco.
Charco is based in Cambridge, England.